Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 protein
- Author(s)
- Nguyen, W; Boulet, C; Dans, MG; Loi, K; Jarman, KE; Watson, GM; Tham, WH; Fairhurst, KJ; Yeo, T; Fidock, DA; Wittlin, S; Chowdury, M; de Koning-Ward, TF; Chen, G; Yan, D; Charman, SA; Baud, D; Brand, S; Jackson, PF; Cowman, AF; Gilson, PR; Sleebs, BE;
- Journal Title
- European Journal of Medicinal Chemistry
- Abstract
- Malaria is a devastating disease that causes significant morbidity worldwide. The development of new antimalarial chemotypes is urgently needed because of the emergence of resistance to frontline therapies. Independent phenotypic screening campaigns against the Plasmodium asexual parasite, including our own, identified the aryl amino acetamide hit scaffold. In a prior study, we identified the STAR-related lipid transfer protein (PfSTART1) as the molecular target of this antimalarial chemotype. In this study, we combined structural elements from the different aryl acetamide hit subtypes and explored the structure-activity relationship. It was shown that the inclusion of an endocyclic nitrogen, to generate the tool compound WJM-715, improved aqueous solubility and modestly improved metabolic stability in rat hepatocytes. Metabolic stability in human liver microsomes remains a challenge for future development of the aryl acetamide class, which was underscored by modest systemic exposure and a short half-life in mice. The optimized aryl acetamide analogs were cross resistant to parasites with mutations in PfSTART1, but not to other drug-resistant mutations, and showed potent binding to recombinant PfSTART1 by biophysical analysis, further supporting PfSTART1 as the likely molecular target. The optimized aryl acetamide analogue, WJM-715 will be a useful tool for further investigating the druggability of PfSTART1 across the lifecycle of the malaria parasite.
- Publisher
- Elsevier
- Keywords
- Antimalarial; Aryl amino acetamide; Malaria; Plasmodium; STAR lipid transfer
- Research Division(s)
- Chemical Biology; Advanced Technology And Biology; Immunology; Infectious Diseases And Immune Defence
- PubMed ID
- 38554474
- Publisher's Version
- https://doi.org/10.1016/j.ejmech.2024.116354
- Open Access at Publisher's Site
https://doi.org/10.1016/j.ejmech.2024.116354- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-04-08 12:14:53
Last Modified: 2024-04-08 02:51:50